OFFICIAL PUBLICATION OF

by its subsidiary APPco

Downscheduling welcomed

Chris Brooker 08/05/2020

Downscheduling of migraine treatments begins on 1 Feb The Pharmacy Guild of Australia welcomed the confirmed decision to down-schedule the migraine treatments sumatriptan and zolmitriptan to S3, or pharmacist-only, medicines. In a decision released on 7 May, the Therapeutic Goods Administration (TGA) scheduling committee decided Sumatriptan would be in Schedule 3 "when in divided oral

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

Downscheduling welcomed

Previous Allergic rhinitis: more than a sniffle & a sneeze

Next The week in review

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Allergic rhinitis: more than a sniffle & a sneeze

Next The week in review

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.